1. The impact of dual antiplatelet therapy duration on primary composite endpoint after drug-eluting stent implantation: A meta-analysis of 10 randomized trials
- Author
-
Shao-Liang Chen, Hao Zhu, Christos V Bourantas, Yaping Zeng, Xiao-Yun Chen, Bo Xu, Xiao-Min Ren, Yao-Jun Zhang, Shun-Yi Shi, Patrick W. Serruys, Javaid Iqbal, Gabriel Bioh, Si Pang, and Cardiology
- Subjects
medicine.medical_specialty ,Endpoint Determination ,medicine.medical_treatment ,education ,030204 cardiovascular system & hematology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Therapy duration ,Humans ,030212 general & internal medicine ,Randomized Controlled Trials as Topic ,Aspirin ,business.industry ,Drug-Eluting Stents ,social sciences ,humanities ,Drug-eluting stent ,Cardiovascular Diseases ,Meta-analysis ,Family medicine ,Cardiology ,population characteristics ,Platelet aggregation inhibitor ,Cardiology and Cardiovascular Medicine ,business ,Platelet Aggregation Inhibitors - Abstract
a Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China b Sheffield Teaching Hospitals and the University of Sheffield, Sheffield, United Kingdom c Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands d Department of Cardiology, University College London Hospital, London, United Kingdom e Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Beijing 100037, China f International Centre for Circulatory Health, Imperial College London, London, United Kingdom
- Published
- 2016
- Full Text
- View/download PDF